Successful Treatment of Pericardial Drainage and Platinum-Based Chemotherapy in a Case of BRCA-Positive Serous Peritoneal Carcinoma Complicated by Cardiac Tamponade

Cases of serous peritoneal carcinoma complicated by cardiac tamponade due to cancerous pericardial effusion are extremely rare and have poor prognoses. We report a case of a 72-year-old patient who presented with epigastric discomfort and was diagnosed with serous peritoneal carcinoma complicated by cardiac tamponade. The patient underwent emergency pericardial drainage for the cardiac tamponade. Subsequently, she was diagnosed with BRCA1-positive peritoneal carcinoma and was administered carboplatin, paclitaxel, and bevacizumab. After treatment initiation, cancer antigen 125 levels decreased rapidly, and no recurrence of pericardial effusion was observed. CT after four cycles of chemotherapy showed the disappearance of peritoneal dissemination and ascites. The patient completed six courses of induction chemotherapy and was scheduled to undergo maintenance therapy with PARP inhibitors. We report the first case of effective platinum-based chemotherapy in a patient with BRCA-positive peritoneal cancer complicated by cardiac tamponade. Chemotherapy has advanced dramatically in recent years, and even in cases with complications, such as cardiac tamponade, appropriate treatment can lead to a favorable long-term prognosis.

• Publication year

  2025

• Venue

  Cureus

• Publication date

  2025-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.7759/cureus.94150PMID 41209924PMCID 12594548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

  2024cited by this paper
• Cytology positive pericardial effusion causing tamponade in patients with high grade serous carcinoma of the ovary

  2020cited by this paper
• Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

  2019cited by this paper
• Echocardiographic Evaluation of Pericardial Effusion and Cardiac Tamponade

  2017cited by this paper
• Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.

  2016cited by this paper
• BRCAness revisited

  2016cited by this paper
• Inherited Mutations in Women With Ovarian Carcinoma.

  2016cited by this paper
• Clinical Communications: Obstetrics and Gynecology MALIGNANT PERICARDIAL EFFUSION IN OVARIAN MALIGNANCY: A TREATABLE ONCOLOGIC EMERGENCY

  2015cited by this paper
• Management of Malignant Pericardial Effusion

  2014cited by this paper
• Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

  2013cited by this paper
• Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer

  2012cited by this paper
• Integrated Genomic Analyses of Ovarian Carcinoma

  2011cited by this paper
• Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004

  2009cited by this paper
• Large Symptomatic Pericardial Effusion as the Presentation of Unrecognized Cancer: A Study in 173 Consecutive Patients Undergoing Pericardiocentesis

  2006cited by this paper
• Malignant pericardial effusion with cardiac tamponade in a patient with metastatic vaginal adenocarcinoma

  2005cited by this paper
• Malignant effusive disease of the pleura and pericardium.

  1997cited by this paper
• Malignancy‐related pericardial effusion. 127 cases from the roswell park cancer institute

  1995cited by this paper
• Cardiac tamponade as a presentation of extracardiac malignancy

  1980cited by this paper

• No citing papers are available for this paper.